| Trial ID: | L0810 |
| Source ID: | NCT03319199
|
| Associated Drug: |
L-CARNITINE
|
| Title: |
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver, Nonalcoholic
|
| Interventions: |
Dietary Supplement: "SLIM WATER";Other: Placebo - water
|
| Outcome Measures: |
The primary outcome is decline in serum levels of Aspartate transaminase (AST) to normal value.;Decline in serum levels of Alanine transaminase (ALT) to normal value.Improvement in radiological hepatic steatosis .;Improvement in lipid profile.
|
| Sponsor/Collaborators: |
Rawi Hazzan
|
| Gender: |
All
|
| Age: |
18 Years75 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
22
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
|
| Start Date: |
10/10/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT03319199
|
